Cargando…
P549: EFFICACY AND TOXICITY OF CPX-351 IN PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA (AML): THE MULTICENTER REAL-WORLD EXPERIENCE FROM THE “ITALIAN TRIVENETO REGISTRY”.
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429036/ http://dx.doi.org/10.1097/01.HS9.0000969104.08302.5e |
_version_ | 1785090614783639552 |
---|---|
author | Luca Morelli, Gian Fili, Carla Mauro, Endri Maria Scattolin, Anna Mosna, Federico Gurrieri, Carmela Nadali, Gianpaolo Lico, Albana Sperotto, Alessandra DE Bellis, Eleonora Michieli, Mariagrazia Aloisi, Teresa Lazzarotto, Davide Elena Zannier, Maria Simeone, Erica Alzetta, Daniel Battaglia, Giulia Callegari, Chiara Pizzano, Umberto Mullai, Rikard Tosoni, Luca Tiribelli, Mario Fanin, Renato |
author_facet | Luca Morelli, Gian Fili, Carla Mauro, Endri Maria Scattolin, Anna Mosna, Federico Gurrieri, Carmela Nadali, Gianpaolo Lico, Albana Sperotto, Alessandra DE Bellis, Eleonora Michieli, Mariagrazia Aloisi, Teresa Lazzarotto, Davide Elena Zannier, Maria Simeone, Erica Alzetta, Daniel Battaglia, Giulia Callegari, Chiara Pizzano, Umberto Mullai, Rikard Tosoni, Luca Tiribelli, Mario Fanin, Renato |
author_sort | Luca Morelli, Gian |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10429036 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104290362023-08-17 P549: EFFICACY AND TOXICITY OF CPX-351 IN PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA (AML): THE MULTICENTER REAL-WORLD EXPERIENCE FROM THE “ITALIAN TRIVENETO REGISTRY”. Luca Morelli, Gian Fili, Carla Mauro, Endri Maria Scattolin, Anna Mosna, Federico Gurrieri, Carmela Nadali, Gianpaolo Lico, Albana Sperotto, Alessandra DE Bellis, Eleonora Michieli, Mariagrazia Aloisi, Teresa Lazzarotto, Davide Elena Zannier, Maria Simeone, Erica Alzetta, Daniel Battaglia, Giulia Callegari, Chiara Pizzano, Umberto Mullai, Rikard Tosoni, Luca Tiribelli, Mario Fanin, Renato Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429036/ http://dx.doi.org/10.1097/01.HS9.0000969104.08302.5e Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Luca Morelli, Gian Fili, Carla Mauro, Endri Maria Scattolin, Anna Mosna, Federico Gurrieri, Carmela Nadali, Gianpaolo Lico, Albana Sperotto, Alessandra DE Bellis, Eleonora Michieli, Mariagrazia Aloisi, Teresa Lazzarotto, Davide Elena Zannier, Maria Simeone, Erica Alzetta, Daniel Battaglia, Giulia Callegari, Chiara Pizzano, Umberto Mullai, Rikard Tosoni, Luca Tiribelli, Mario Fanin, Renato P549: EFFICACY AND TOXICITY OF CPX-351 IN PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA (AML): THE MULTICENTER REAL-WORLD EXPERIENCE FROM THE “ITALIAN TRIVENETO REGISTRY”. |
title | P549: EFFICACY AND TOXICITY OF CPX-351 IN PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA (AML): THE MULTICENTER REAL-WORLD EXPERIENCE FROM THE “ITALIAN TRIVENETO REGISTRY”. |
title_full | P549: EFFICACY AND TOXICITY OF CPX-351 IN PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA (AML): THE MULTICENTER REAL-WORLD EXPERIENCE FROM THE “ITALIAN TRIVENETO REGISTRY”. |
title_fullStr | P549: EFFICACY AND TOXICITY OF CPX-351 IN PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA (AML): THE MULTICENTER REAL-WORLD EXPERIENCE FROM THE “ITALIAN TRIVENETO REGISTRY”. |
title_full_unstemmed | P549: EFFICACY AND TOXICITY OF CPX-351 IN PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA (AML): THE MULTICENTER REAL-WORLD EXPERIENCE FROM THE “ITALIAN TRIVENETO REGISTRY”. |
title_short | P549: EFFICACY AND TOXICITY OF CPX-351 IN PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA (AML): THE MULTICENTER REAL-WORLD EXPERIENCE FROM THE “ITALIAN TRIVENETO REGISTRY”. |
title_sort | p549: efficacy and toxicity of cpx-351 in patients with high-risk acute myeloid leukemia (aml): the multicenter real-world experience from the “italian triveneto registry”. |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429036/ http://dx.doi.org/10.1097/01.HS9.0000969104.08302.5e |
work_keys_str_mv | AT lucamorelligian p549efficacyandtoxicityofcpx351inpatientswithhighriskacutemyeloidleukemiaamlthemulticenterrealworldexperiencefromtheitaliantrivenetoregistry AT filicarla p549efficacyandtoxicityofcpx351inpatientswithhighriskacutemyeloidleukemiaamlthemulticenterrealworldexperiencefromtheitaliantrivenetoregistry AT mauroendri p549efficacyandtoxicityofcpx351inpatientswithhighriskacutemyeloidleukemiaamlthemulticenterrealworldexperiencefromtheitaliantrivenetoregistry AT mariascattolinanna p549efficacyandtoxicityofcpx351inpatientswithhighriskacutemyeloidleukemiaamlthemulticenterrealworldexperiencefromtheitaliantrivenetoregistry AT mosnafederico p549efficacyandtoxicityofcpx351inpatientswithhighriskacutemyeloidleukemiaamlthemulticenterrealworldexperiencefromtheitaliantrivenetoregistry AT gurriericarmela p549efficacyandtoxicityofcpx351inpatientswithhighriskacutemyeloidleukemiaamlthemulticenterrealworldexperiencefromtheitaliantrivenetoregistry AT nadaligianpaolo p549efficacyandtoxicityofcpx351inpatientswithhighriskacutemyeloidleukemiaamlthemulticenterrealworldexperiencefromtheitaliantrivenetoregistry AT licoalbana p549efficacyandtoxicityofcpx351inpatientswithhighriskacutemyeloidleukemiaamlthemulticenterrealworldexperiencefromtheitaliantrivenetoregistry AT sperottoalessandra p549efficacyandtoxicityofcpx351inpatientswithhighriskacutemyeloidleukemiaamlthemulticenterrealworldexperiencefromtheitaliantrivenetoregistry AT debelliseleonora p549efficacyandtoxicityofcpx351inpatientswithhighriskacutemyeloidleukemiaamlthemulticenterrealworldexperiencefromtheitaliantrivenetoregistry AT michielimariagrazia p549efficacyandtoxicityofcpx351inpatientswithhighriskacutemyeloidleukemiaamlthemulticenterrealworldexperiencefromtheitaliantrivenetoregistry AT aloisiteresa p549efficacyandtoxicityofcpx351inpatientswithhighriskacutemyeloidleukemiaamlthemulticenterrealworldexperiencefromtheitaliantrivenetoregistry AT lazzarottodavide p549efficacyandtoxicityofcpx351inpatientswithhighriskacutemyeloidleukemiaamlthemulticenterrealworldexperiencefromtheitaliantrivenetoregistry AT elenazanniermaria p549efficacyandtoxicityofcpx351inpatientswithhighriskacutemyeloidleukemiaamlthemulticenterrealworldexperiencefromtheitaliantrivenetoregistry AT simeoneerica p549efficacyandtoxicityofcpx351inpatientswithhighriskacutemyeloidleukemiaamlthemulticenterrealworldexperiencefromtheitaliantrivenetoregistry AT alzettadaniel p549efficacyandtoxicityofcpx351inpatientswithhighriskacutemyeloidleukemiaamlthemulticenterrealworldexperiencefromtheitaliantrivenetoregistry AT battagliagiulia p549efficacyandtoxicityofcpx351inpatientswithhighriskacutemyeloidleukemiaamlthemulticenterrealworldexperiencefromtheitaliantrivenetoregistry AT callegarichiara p549efficacyandtoxicityofcpx351inpatientswithhighriskacutemyeloidleukemiaamlthemulticenterrealworldexperiencefromtheitaliantrivenetoregistry AT pizzanoumberto p549efficacyandtoxicityofcpx351inpatientswithhighriskacutemyeloidleukemiaamlthemulticenterrealworldexperiencefromtheitaliantrivenetoregistry AT mullairikard p549efficacyandtoxicityofcpx351inpatientswithhighriskacutemyeloidleukemiaamlthemulticenterrealworldexperiencefromtheitaliantrivenetoregistry AT tosoniluca p549efficacyandtoxicityofcpx351inpatientswithhighriskacutemyeloidleukemiaamlthemulticenterrealworldexperiencefromtheitaliantrivenetoregistry AT tiribellimario p549efficacyandtoxicityofcpx351inpatientswithhighriskacutemyeloidleukemiaamlthemulticenterrealworldexperiencefromtheitaliantrivenetoregistry AT faninrenato p549efficacyandtoxicityofcpx351inpatientswithhighriskacutemyeloidleukemiaamlthemulticenterrealworldexperiencefromtheitaliantrivenetoregistry |